Barclays’s Cellcom Israel, Ltd. CEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,420
| Closed | -$39K | – | 5216 |
|
|
2021
Q1 | $39K | Buy |
+10,420
| New | +$46.5K | ﹤0.01% | 4254 |
|
|
2019
Q4 | – | Sell |
-3,439
| Closed | -$10K | – | 7077 |
|
|
2019
Q3 | $10K | Buy |
3,439
+184
| +6% | +$476 | ﹤0.01% | 6354 |
|
|
2019
Q2 | $9K | Hold |
3,255
| – | – | ﹤0.01% | 6595 |
|
|
2019
Q1 | $12K | Buy |
3,255
+2,067
| +174% | +$9.96K | ﹤0.01% | 6521 |
|
|
2018
Q4 | $7K | Buy |
+1,188
| New | +$7.76K | ﹤0.01% | 6354 |
|
|
2017
Q4 | – | Sell |
-743
| Closed | -$7K | – | 7230 |
|
|
2017
Q3 | $7K | Sell |
743
-5,926
| -89% | -$54.3K | ﹤0.01% | 6312 |
|
|
2017
Q2 | $64K | Buy |
+6,669
| New | +$65.9K | ﹤0.01% | 5210 |
|
|
2016
Q4 | – | Sell |
-16,100
| Closed | -$121K | – | 6944 |
|
|
2016
Q3 | $121K | Sell |
16,100
-9,200
| -36% | -$67K | ﹤0.01% | 4373 |
|
|
2016
Q2 | $166K | Sell |
25,300
-2,100
| -8% | -$15.6K | ﹤0.01% | 4062 |
|
|
2016
Q1 | $192K | Sell |
27,400
-932
| -3% | -$5.89K | ﹤0.01% | 3880 |
|
|
2015
Q4 | $170K | Buy |
28,332
+7,932
| +39% | +$55.3K | ﹤0.01% | 4035 |
|
|
2015
Q3 | $123K | Buy |
+20,400
| New | +$121K | ﹤0.01% | 4475 |
|
|
2015
Q2 | – | Sell |
-5,062
| Closed | -$20K | – | 7297 |
|
|
2015
Q1 | $20K | Buy |
5,062
+4,677
| +1,215% | +$26.8K | ﹤0.01% | 5838 |
|
|
2014
Q4 | $3K | Sell |
385
-31,549
| -99% | -$308K | ﹤0.01% | 7084 |
|
|
2014
Q3 | $320K | Buy |
31,934
+30,984
| +3,261% | +$367K | ﹤0.01% | 4348 |
|
|
2014
Q2 | $11K | Hold |
950
| – | – | ﹤0.01% | 6800 |
|
|
2014
Q1 | $12K | Hold |
950
| – | – | ﹤0.01% | 6851 |
|
|
2013
Q4 | $12K | Buy |
+950
| New | +$12K | ﹤0.01% | 6948 |
|
|
2013
Q3 | – | Sell |
-2,239
| Closed | -$21K | – | 7695 |
|
|
2013
Q2 | $21K | Buy |
+2,239
| New | +$20.3K | ﹤0.01% | 6820 |
|
Other funds holding CEL
Barclays's CEL Position: Q2 2021 in Review
Barclays sold out of Cellcom Israel, Ltd. (CEL) in Q2 2021, closing a stake of 10,420 shares — an estimated $39K sold.
Barclays first reported a position in CEL in Q2 2013 and held it in 19 quarters. The position peaked at $320K in Q3 2014. 3 funds tracked by Wall St. Rank hold CEL as of Q2 2021.
- Barclays reported no remaining Cellcom Israel, Ltd. position as of Q2 2021 after selling out during the quarter.
- Barclays sold 10,420 Cellcom Israel, Ltd. shares in Q2 2021, an estimated $39K.
- Barclays first reported a position in Cellcom Israel, Ltd. in Q2 2013 and held it in 19 quarters.
- Barclays's Cellcom Israel, Ltd. position peaked at $320K in Q3 2014.
- 3 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q2 2021.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.